Cipla Ltd (CIPLA) — Announcement | 31 August 2026
Cipla announced on August 31, 2026 that it signed an exclusive licensing agreement with SBP Group’s subsidiary CTTQ to develop and commercialize TQB2102, a HER2 bispecific ADC, in India, South Africa, and five emerging markets, leveraging Cipla’s regulatory and commercial infrastructure to accelerate patient access.
About Cipla Ltd (CIPLA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when CIPLA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CIPLA — Free💡 Ask AI about this filing
📊 More CIPLA filings
- 🔴 Announcement — 28 August 2026 Cipla disclosed that the USFDA classified its Invagen manufacturing facility inspection in Central I...
- 🔴 Announcement — 27 August 2026 Cipla announced a restructuring where Aspergen Limited, India acquired 100% of Aspergen Inc., USA fr...
- 🔴 Announcement — 27 August 2026 Cipla announced its schedule for upcoming analyst and institutional investor meetings in September 2...
- 🔴 Corporate Action — 26 August 2026 Cipla announced the allotment of 5,281 fully paid-up equity shares of INR 2 each under its ESOS 2013...
- Announcement — 25 August 2026 Cipla announced that the USFDA completed a follow-up cGMP inspection at its Pithampur facility from ...
🔥 Also filed on 31 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CIPLA files new disclosures
Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CIPLA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd